Jia Ding

Jia Ding

Auto-generated profile, based on publicly available information

Jia Ding

Department of Gastroenterology, Shanghai Jing'an District Central Hospital Fudan University Shanghai China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
JDJia Ding
Jia Ding
HLHui-Yan Li
Hui-Yan Li
LZLi Zhang
Li Zhang
YZYuan Zhou
Yuan Zhou
Jian WuJian Wu
Jian Wu
Hedgehog (Hh) signaling is a classic morphogen in controlling embryonic development and tissue repairing. Aberrant activation of Hh signaling has been well documented in liver cancer, including hepatoblastoma, hepatocellular carcinoma (HCC) and cholangiocarcinoma. The present review aims to update the current understanding on how abnormal Hh signaling molecules modulate initiation, progression, drug resistance and metastasis of HCC. The latest relevant literature was reviewed with our recent findings to provide an overview regarding the molecular interplay and clinical relevance of the Hh signaling in HCC management. Hh signaling molecules are involved in the transformation of pre-carcinogenic lesions to malignant features in chronic liver injury, such as nonalcoholic steatohepatitis. Activation of GLI target genes, such as ABCC1 and TAP1, is responsible for drug resistance in hepatoma cells, with a CD133−/EpCAM− surface molecular profile, and GLI1 and truncated GLI1 account for the metastatic feature of the hepatoma cells, with upregulation of matrix metalloproteinases. A novel bioassay for the Sonic Hh ligand in tissue specimens may assist HCC diagnosis with negative α-fetoprotein and predict early microvascular invasion. In-depth exploration of the Hh signaling deepens our understanding of its molecular modulation in HCC initiation, drug sensitivity and metastasis, and guides precise management of HCC on an individual basis.

1 July 2017 in Laboratory Investigation
Verified
Journal Article
Closed access
JDJia Ding
Jia Ding
XZXiao-Tian Zhou
Xiao-Tian Zhou
HZHaoyu Zou
Haoyu Zou
Jian WuJian Wu
Jian Wu

16 March 2015 in Oncogene
Verified
Journal Article
Open access
PDF file
YFY-H Fan
Y-H Fan
JDJ Ding
J Ding
SNS Nguyen
S Nguyen
XLX-J Liu
X-J Liu
GXG Xu
G Xu
JWJ Wu
J Wu
Hepatoma exhibits a series of heterogeneous subpopulations in its cell surface markers, tumorigenicity, invasion and metastatic capability. We previously demonstrated that the CD133−/EpCAM− hepatoma subpopulation was more metastatic than its counterpart; however, the controlling mechanisms are unexplored. The present study aimed to delineate the significance of aberrant hedgehog (Hh) signaling in the mediation of metastases. Fluorescence-activated cell sorting-enriched CD133−/EpCAM− (double negative, DN), Huh-7 cells underwent a transwell selection for metastatic cells (transwell-selected, TS). The TS cells displayed much greater metastatic activity as evidenced by an increased invasion rate, extremely upregulated expression of matrix metalloproteinase (MMP)-1/2/9 genes compared with DN and double-positive (DP) subpopulations. In contrast to DP cells, TS cells lost E-cadherin and were all vimentin-positive as shown by immunocytochemistry. There was a transitional increase in Gli-1/2 gene expression levels from DP, DN to TS subpopulations, which was consistent with elevated Gli-1/2 or Twist-1 protein levels in the nuclear fraction. Furthermore, truncated Gli-1 (tGli-1), which transactivates molecules involved in metastasis, was detected in the highly invasive Huh-7 cell subpopulation, but not in less metastatic hepatoma cells or normal hepatocytes. The enhanced metastatic features with increased expression of MMPs as well as the presence of twist and snail genes in TS Huh-7 cells were reversed by LDE225, a potent Smoothened antagonist. In conclusion, the highly metastatic capability of a unique TS subpopulation was highly attributed to significant epithelial–mesenchymal transition, enhanced Hh activity and aberrant occurrence of a tGli-1 variant, which appears to be responsible for the highly invasive behavior.

1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
YZYuan Zhou
Yuan Zhou
LZLi Zhang
Li Zhang
YMYue Ma
Yue Ma
LXLi Xie
Li Xie
YYYong-Yu Yang
Yong-Yu Yang
Jian WuJian Wu
Jian Wu
Background: Hepatic fibrosis is a premalignant lesion, and how injured hepatocytes transform into malignancy in a fibrotic microenvironment is poorly understood. Senescence is one of major fates of activated hepatic stellate cells (HSCs). Paucity of literature is available regarding the influence of senescent HSCs on behavior of steatotic hepatocytes.

28 February 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
XZXiao‐Tian Zhou
Xiao‐Tian Zhou
JDJia Ding
Jia Ding
HLHui‐Yan Li
Hui‐Yan Li
JZJie‐Liang Zuo
Jie‐Liang Zuo
SGSheng‐Yang Ge
Sheng‐Yang Ge
Jian WuJian Wu
Jian Wu
Multidrug resistance is one of the reasons for low survival of advanced hepatocellular carcinoma (HCC). Our previous studies indicate that the hedgehog signalling is involved in hepatic carcinogenesis, metastasis and chemo‐resistance. The present study aims to uncover molecular mechanisms underlying hepatoma chemo‐resistance. TAP1 and GLI1/2 gene expression was assessed in both poorly differentiated hepatoma cells and HCC specimens. Potential GLI‐binding site in the TAP1 promoter sequence was validated by molecular assays. Approximately 75% HCC specimens exhibited an elevated expression of hedgehog GLI1 transcription factor compared with adjacent liver tissue. Both GLI1/2 and TAP1 protein levels were significantly elevated in poorly differentiated hepatoma cells. Both Huh‐7‐trans and Huh‐7‐DN displayed more karyotypic abnormalities and differential gene expression profiles than their native Huh‐7 cells. Sensitivity to Sorafenib, doxorubicin and cisplatin was remarkably improved after either GLI1 or TAP1 gene was inhibited by an RNAi approach or by a specific GLI1/2 inhibitor, GANT61. Further experiments confirmed that hedgehog transcription factor GLI1/2 binds to the TAP1 promoter, indicating that TAP1 is one of GLI1/2 target genes. In conclusion, TAP1 is under direct transcriptional control of the hedgehog signalling. Targeting hedgehog signalling confers a novel insight into alleviating drug resistance in the treatment of refractory HCC.

5 March 2024 in Cancer Letters
Verified
Journal Article
Closed access
JDJia Ding
Jia Ding
YYYong-Yu Yang
Yong-Yu Yang
PLPeng-Tao Li
Peng-Tao Li
YMYue Ma
Yue Ma
LZLi Zhang
Li Zhang
Jian WuJian Wu
Jian Wu